DNA of Biopreneur A.S.Rao Adviser-Innovation Clusters,FMC firstname.lastname@example.org http://www.indiainvents.blogspot.com/
Molecule millionaires Scientist turned promoter: Dr Anji Reddy (DPR), Ketan R Patel(Troikka), Krishna Ella (Bharat Biotech), Ramanbhai Patel(Cadia), Biopreneurs: Ranbir Singh & Gurbax Singh (Ranbaxy), UN Mehta (Torrent), Varaprasad Reddy (Shanta Biotech), Raghavendrarao (Orchid)
Signature of success Master the virtuous cycle of knowledge management. Identify business opportunity, decipher key factors, relate to technology, acquire technology and raise the stock of Firm Specific Knowledge. Learn to network with knowledge partners and knowledge workers. Lead cluster formation as network orchestrator
Opportunities Patents not enforced in India Drugs going off the patents Affordable health care 100 global technologies shortlisted by knowledge partner Sky Quest.
Patents not enforced in India http://www.globalinnovationcommons.org Buruli Ulcer, Dengue Fever, Dracunculiasis(Guinea Worm Disease), Leprosy, Lymphatic Filariasis, Malaria, Sickle Cell Anemia, Snake Bite, Spider Bite
Going off the patent 22 drugs will go off-patent in India by 2015-Rituxan, an anti-neoplasticmAbs from Roche; Lantus, an antidiabetics from Sanofiaventis; and Neulasta, an immunostimulants from Amgen; have record sales of $5.6 billion, $4.3 billion and $3.4 billion respectively. Similarly, Epogen from Amgen, Avonex from Biogen Idec, Eprex from Johnson & Johnson and Rebif from Merck, which reported sales of over $2 billion in 2009, will lose patents by 2013.
Affordable health care Service innovations: Eye care, Heart surgery, Tele medicine, remote monitoring of patients, Reverse innovations: from Innovators/ start-ups –Mosquito traps, infant warmers Non-profit design centers: http://www.d-rev.org/index.html
Services needed Technology search, access, acquisition, negotiation Business plan Regulatory approvals